Local view for "https://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/Evidence/1412"
| Predicate | Value (sorted: default) |
|---|---|
| rdfs:label | |
| rdf:type | |
| ?:Evidence_enzyme_system | |
| ?:Evidence_numb_subjects | |
| ?:Evidence_object_dose | |
| ?:Evidence_precip_dose | |
| ?:Evidence_type | |
| ?:Evidence_value |
"3.87"
|
| ?:content |
"Route of administration: oral
study duration: 5-phase randomized cross-over study with participants receiving a single oral dose of .25mg triazolam either simultaneously or 3,12, or 24 hours before triazolam
population: 10
male: 6
female: 4
ages: 19-27
AUC_i/AUC 0 to infinity (itra simultaneous w/ TRZ): 38.2/12.3 = 3.1
AUC_i/AUC 0 to infinity (itra 3 hours prior to TRZ): 55.1/12.3 = 4.48
AUC_i/AUC 0 to infinity (itra 12 hours prior to TRZ): 53.2/12.3 = 4.33
AUC_i/AUC 0 to infinity (itra 24 hours prior to TRZ): 43.9/12.3 = 3.57
Average: 3.87"
|
| dc:creator | |
| dc:date |
"10/29/2007 12:59:15"
|
| rdfs:seeAlso |
All properties reside in the graph file:///home/swish/src/ClioPatria/guidelines/dikb.ttl
The resource appears as object in one triple:
{ itraconazole_increases_auc_triazolam, <http://purl.org/swan/1.2/swan-commons#citesAsSupportingEvidence>, evidence_1002 }